Publications
- Guselkumab - první inhibitor IL-23 v léčbě psoriázy2019 | Third Faculty of Medicine
- Treatment of Severe Atopic Dermatitis with Dupilumab in Patients with Advanced Cancer2023 | Third Faculty of Medicine
- Závažná forma atopické dermatitidy - úspěšná léčba abrocitinibem2023 | Third Faculty of Medicine
- Severe form of atopic dermatitis - Successful treatment with abrocitinib2023 | Third Faculty of Medicine
- Dupilumab for the treatment of atopic dermatitis: Real-world data from the Czech Republic BIOREP registry2022 | Third Faculty of Medicine, First Faculty of Medicine, Faculty of Medicine in Pilsen, Central Library of Charles University
- Real-life experience in the effectiveness, impact on quality of life and safety of dupilumab treatment in patients with moderate to severe atopic dermatitis in the Czech Republic2022 | Third Faculty of Medicine, First Faculty of Medicine, Central Library of Charles University
- Case studies in dermatology2021 | Third Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport, Faculty of Medicine in Pilsen
- Improvement of atopic dermatitis and IgA nephropathy in a patient treated by dupilumab2021 | Third Faculty of Medicine
- 5 Zlepšení atopické dermatitidy A IgA nefropatie u pacienta léčeného dupilumabem2021 | Third Faculty of Medicine
- Ocular complications in atopic dermatitis and a case study of a patient with severe ocular complications treated with dupilumab2020 | Third Faculty of Medicine, First Faculty of Medicine
Loading network view...